These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23531079)

  • 21. Vandetanib sensitizes head and neck squamous cell carcinoma to photodynamic therapy through modulation of EGFR-dependent DNA repair and the tumour microenvironment.
    Chu PL; Shihabuddeen WA; Low KP; Poon DJJ; Ramaswamy B; Liang ZG; Nei WL; Chua KLM; Thong PSP; Soo KC; Yeo ELL; Chua MLK
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():367-374. PubMed ID: 31299389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanophotosensitizers toward advanced photodynamic therapy of Cancer.
    Lim CK; Heo J; Shin S; Jeong K; Seo YH; Jang WD; Park CR; Park SY; Kim S; Kwon IC
    Cancer Lett; 2013 Jul; 334(2):176-87. PubMed ID: 23017942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted photodynamic therapy in head and neck squamous cell carcinoma: heading into the future.
    Marchal S; Dolivet G; Lassalle HP; Guillemin F; Bezdetnaya L
    Lasers Med Sci; 2015 Dec; 30(9):2381-7. PubMed ID: 25563461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells.
    Cohen EM; Ding H; Kessinger CW; Khemtong C; Gao J; Sumer BD
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):109-15. PubMed ID: 20620628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Water-Soluble Phthalocyanines Selectively Bind to Albumin Dimers: A Green Approach Toward Enhancing Tumor-Targeted Photodynamic Therapy.
    Li X; Jeong K; Lee Y; Guo T; Lee D; Park J; Kwon N; Na JH; Hong SK; Cha SS; Huang JD; Choi S; Kim S; Yoon J
    Theranostics; 2019; 9(22):6412-6423. PubMed ID: 31588226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
    Broekgaarden M; de Kroon AI; Gulik TM; Heger M
    Curr Med Chem; 2014; 21(3):377-91. PubMed ID: 23931271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimodal Image-Guided Surgical and Photodynamic Interventions in Head and Neck Cancer: From Primary Tumor to Metastatic Drainage.
    Muhanna N; Cui L; Chan H; Burgess L; Jin CS; MacDonald TD; Huynh E; Wang F; Chen J; Irish JC; Zheng G
    Clin Cancer Res; 2016 Feb; 22(4):961-70. PubMed ID: 26463705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.
    Lam M; Hsia AH; Liu Y; Guo M; Swick AR; Berlin JC; McCormick TS; Kenney ME; Oleinick NL; Cooper KD; Baron ED
    Clin Exp Dermatol; 2011 Aug; 36(6):645-51. PubMed ID: 21623875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Photodynamic Therapy of Human Head and Neck Squamous Cell Carcinoma with Anti-epidermal Growth Factor Receptor Antibody Cetuximab and Photosensitizer IR700DX in the Mouse Skin-fold Window Chamber Model.
    Peng W; de Bruijn HS; Ten Hagen TLM; van Dam GM; Roodenburg JLN; Berg K; Witjes MJH; Robinson DJ
    Photochem Photobiol; 2020 May; 96(3):708-717. PubMed ID: 32222965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy.
    Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
    Cancer Res; 2001 Mar; 61(5):1970-5. PubMed ID: 11280754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cisplatin enhances the efficacy of 5-aminolevulinic acid mediated photodynamic therapy in human head and neck squamous cell carcinoma.
    Ahn JC; Biswas R; Mondal A; Lee YK; Chung PS
    Gen Physiol Biophys; 2014; 33(1):53-62. PubMed ID: 23846261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.
    Separovic D; Breen P; Boppana NB; Van Buren E; Joseph N; Kraveka JM; Rahmaniyan M; Li L; Gudz TI; Bielawska A; Bai A; Bielawski J; Pierce JS; Korbelik M
    Int J Oncol; 2013 Dec; 43(6):2064-72. PubMed ID: 24126464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Near-Infrared Activatable Phthalocyanine-Poly-L-Glutamic Acid Conjugate: Enhanced in Vivo Safety and Antitumor Efficacy toward an Effective Photodynamic Cancer Therapy.
    Cheah HY; Gallon E; Dumoulin F; Hoe SZ; Japundžić-Žigon N; Glumac S; Lee HB; Anand P; Chung LY; Vicent MJ; Kiew LV
    Mol Pharm; 2018 Jul; 15(7):2594-2605. PubMed ID: 29763568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-mediated Photodynamic Therapy as a Method to Ablate Oral Cavity Squamous Cell Carcinoma in Preclinical Models.
    Sahovaler A; Valic MS; Townson JL; Chan HHL; Zheng M; Tzelnick S; Mondello T; Pener-Tessler A; Eu D; El-Sayes A; Ding L; Chen J; Douglas CM; Weersink R; Muhanna N; Zheng G; Irish JC
    Cancer Res Commun; 2024 Mar; 4(3):796-810. PubMed ID: 38421899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.
    Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
    Int J Cancer; 2002 Apr; 98(5):793-8. PubMed ID: 11920653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
    Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
    Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges.
    Master A; Livingston M; Sen Gupta A
    J Control Release; 2013 May; 168(1):88-102. PubMed ID: 23474028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
    Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
    Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.
    Azizuddin K; Kalka K; Chiu SM; Ahmad N; Mukhtar H; Separovic D
    Int J Oncol; 2001 Feb; 18(2):411-5. PubMed ID: 11172611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.
    Bhirde AA; Patel V; Gavard J; Zhang G; Sousa AA; Masedunskas A; Leapman RD; Weigert R; Gutkind JS; Rusling JF
    ACS Nano; 2009 Feb; 3(2):307-16. PubMed ID: 19236065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.